Investigating how certain tiny particles from immune cells contribute to lung damage after exposure to harmful gases.

Role of proteolytic extracellular vesicles in halogen gas dependent chronic lung injury

['FUNDING_R01'] · UNIVERSITY OF ALABAMA AT BIRMINGHAM · NIH-10928443

This study is looking at how tiny particles released by immune cells can harm the lungs after exposure to chlorine or bromine gas, and it's aimed at finding ways to help people who might suffer from long-lasting lung problems because of this exposure.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorUNIVERSITY OF ALABAMA AT BIRMINGHAM (nih funded)
Locations1 site (BIRMINGHAM, UNITED STATES)
Trial IDNIH-10928443 on ClinicalTrials.gov

What this research studies

This research focuses on understanding the role of proteolytic extracellular vesicles (EVs) released by immune cells in causing chronic lung injury after exposure to chlorine or bromine gas. The study aims to uncover the mechanisms by which these EVs, which carry enzymes that can damage lung tissue, contribute to the transition from acute to chronic lung injury. By examining the interaction between these EVs and lung cells, the researchers hope to identify potential therapeutic targets to mitigate lung damage. The research involves both laboratory experiments and animal models to simulate the effects of gas exposure.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals who have experienced exposure to chlorine or bromine gas, particularly those with symptoms of acute or chronic lung injury.

Not a fit: Patients who have not been exposed to halogen gases or do not have lung injury may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that prevent or reduce chronic lung injury in patients exposed to harmful gases.

How similar studies have performed: While the specific role of proteolytic EVs in halogen gas toxicity is novel, similar research has shown that extracellular vesicles can play significant roles in other lung injury models.

Where this research is happening

BIRMINGHAM, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: Acute Lung Injury, Acute Pulmonary Injury, Airway Disease

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.